These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 9160569)
1. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Katz RJ; Lott MH; Arbus P; Crocq L; Herlobsen P; Lingjaerde O; Lopez G; Loughrey GC; MacFarlane DJ; McIvor R Anxiety; 1994-1995; 1(4):169-74. PubMed ID: 9160569 [TBL] [Abstract][Full Text] [Related]
2. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Baker DG; Diamond BI; Gillette G; Hamner M; Katzelnick D; Keller T; Mellman TA; Pontius E; Rosenthal M; Tucker P Psychopharmacology (Berl); 1995 Dec; 122(4):386-9. PubMed ID: 8657838 [TBL] [Abstract][Full Text] [Related]
3. Predictors of treatment response in patients with posttraumatic stress disorder. Connor KM; Hidalgo RB; Crockett B; Malik M; Katz RJ; Davidson JR Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):337-45. PubMed ID: 11294480 [TBL] [Abstract][Full Text] [Related]
4. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study. Fahlén T; Nilsson HL; Borg K; Humble M; Pauli U Acta Psychiatr Scand; 1995 Nov; 92(5):351-8. PubMed ID: 8619339 [TBL] [Abstract][Full Text] [Related]
5. Brofaromine in panic disorder: a pilot study with a new reversible inhibitor of monoamine oxidase-A. Garcia-Borreguero D; Lauer CJ; Ozdaglar A; Wiedemann K; Holsboer F; Krieg JC Pharmacopsychiatry; 1992 Nov; 25(6):261-4. PubMed ID: 1494591 [TBL] [Abstract][Full Text] [Related]
6. Is there a role for selective monoamine oxidase inhibitor therapy in bulimia nervosa? A placebo-controlled trial of brofaromine. Kennedy SH; Goldbloom DS; Ralevski E; Davis C; D'Souza JD; Lofchy J J Clin Psychopharmacol; 1993 Dec; 13(6):415-22. PubMed ID: 8120155 [TBL] [Abstract][Full Text] [Related]
7. MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study. van Vliet IM; Westenberg HG; Den Boer JA Psychopharmacology (Berl); 1993; 112(4):483-9. PubMed ID: 7871061 [TBL] [Abstract][Full Text] [Related]
8. Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor. van Vliet IM; den Boer JA; Westenberg HG Eur Neuropsychopharmacol; 1992 Mar; 2(1):21-9. PubMed ID: 1638170 [TBL] [Abstract][Full Text] [Related]
9. A cross-study comparison of the effects of moclobemide and brofaromine on actual driving performance and estimated sleep. Ramaekers JG; van Veggel LM; O'Hanlon JF Clin Neuropharmacol; 1994; 17 Suppl 1():S9-18. PubMed ID: 7954488 [TBL] [Abstract][Full Text] [Related]
10. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies. Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397 [TBL] [Abstract][Full Text] [Related]
11. A Canadian multicentre placebo-controlled study of a fixed dose of brofaromine, a reversible selective MAO-A inhibitor, in the treatment of major depression. Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA J Affect Disord; 1994 Oct; 32(2):105-14. PubMed ID: 7829762 [TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants. Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies. Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():426A-427A. PubMed ID: 1498901 [No Abstract] [Full Text] [Related]
17. Brofaromine in major depressed patients: a controlled clinical trial versus imipramine and open follow-up of up to one year. Möller HJ; Volz HP J Affect Disord; 1992 Nov; 26(3):163-72. PubMed ID: 1460166 [TBL] [Abstract][Full Text] [Related]